PLE-2616
What doctrine protects the researchers from liability for any untoward events that may occur when a patient with malignant melanoma undergoes experimental treatment despite the lack of knowledge of possible adverse effects?
What doctrine protects the researchers from liability for any untoward events that may occur when a patient with malignant melanoma undergoes experimental treatment despite the lack of knowledge of possible adverse effects?